Quantcast

Latest Cachexia Stories

2008-10-14 03:00:12

GTx, a biopharmaceutical company, has announced positive topline results of a Phase II clinical trial evaluating Ostarine, an investigational selective androgen receptor modulator, in patients with cancer induced muscle loss, also known as cancer cachexia. In this analysis, the study met its primary endpoint of absolute change in total lean body mass (muscle) compared to placebo and the secondary endpoint of muscle function (performance) after 16 weeks of treatment. GTx plans to present...

2008-10-13 06:00:18

GTx, Inc. (NASDAQ: GTXI) today announced topline results of a Phase II clinical trial evaluating Ostarine(TM) (MK-2866), an investigational selective androgen receptor modulator (SARM), in patients with cancer induced muscle loss, also known as cancer cachexia. In this analysis, the study met its primary endpoint of absolute change in total lean body mass (muscle) compared to placebo and the secondary endpoint of muscle function (performance) after 16 weeks of treatment. GTx and Merck &...

2008-07-14 12:00:20

Advanced Viral Research Corp. (OTCBB: ADVR), a cancer therapeutics company, announced today that it has received two Notices of Allowance for patents related to alleviating side effects in patients undergoing treatments for cancer. The first Notice of Allowance is from the U.S. Patent Office for a method to reduce side effects in cancer patients undergoing chemotherapy. The second Notice of Allowance is from the Canadian Patent Office for treating anemia in cancer patients undergoing...

2005-11-14 12:31:52

A new study provides important insight into the mechanisms of a muscle wasting disorder that interferes with treatment for cancer and has a negative impact on patient survival. The research, published in the November issue of Cancer Cell, describes an unexpected link between muscular dystrophy and muscle wasting associated with cancer, and suggests a potential strategy for development of therapies to combat cancer-associated muscle wasting. Muscle wasting, or cachexia, is a severe and...

2005-06-09 17:32:52

Researchers at Oregon Health & Science University's Doernbecher Children's Hospital have uncovered a unique therapeutic strategy to combat cachexia -- severe malnutrition and physical wasting away -- in children and adults with chronic kidney disease (CKD). The study is published in the June issue of the Journal of Clinical Investigation. Although the exact cause of cachexia -- a common life-threatening complication of CKD, cancer, AIDS and heart failure patients -- is unknown,...

2004-11-29 09:00:18

PhytoMedical Technologies, Inc. (OTCBB:PYTO), an early stage research based biopharmaceutical company specializing in the discovery, development and eventual commercialization of innovative plant derived pharmaceutical and nutraceutical compounds, announces its plans to expand its research and development efforts into two of the leading causes of mortality today - obesity and diabetes. Obesity, according to the U.S. Surgeon General Richard Carmona, is the "fastest-growing cause of illness...


Word of the Day
cruet
  • A vial or small glass bottle, especially one for holding vinegar, oil, etc.; a caster for liquids.
This word is Middle English in origin, and ultimately comes from the Old French, diminutive of 'crue,' flask.
Related